Data Bridge Market Research recently added “
Smart Diabetes Management Market by manufacturers, regions, type and application, forecast to 2028” in his database. This research report focus on complete assessment of market and contains future trend, growth factors, attentive opinions, facts, historical data, statistically supported and industry-validated market data. Environmental concerns & regulatory guidelines regarding release of effluents through different industries.
Smart Diabetes Management Market comprehensive coverage of underlying economic and technological factors under key trend analysis.
Global Smart Diabetes Management Market By Devices (Smart Glucose Meters, Continuous Glucose Monitoring Systems, Smart Insulin Pens, Smart Insulin Pumps, Closed Loop Systems), Devices Type (Handheld Devices, Wearable Devices), Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps), Diabetes Type (Type 1 Diabetes, Type 2 Diabetes), End Use (Home Healt
Tidepool Loop App for Automating Insulin Dosing Now with FDA
Written by Mike Hoskins and Amy Tenderich on February 1, 2021 Fact checked by Jennifer Chesak
Courtesy of Tidepool
Tidepool Loop, a first-of-its-kind app that will connect with a variety of compatible insulin pumps and continuous glucose monitors (CGMs) to automate insulin dosing, has been submitted for FDA approval.
This is big, Diabetes Friends, because new automated insulin delivery (AID) systems are the future of diabetes care, and because the Tidepool Loop project represents over two years of development work aimed at bringing do-it-yourself (DIY) “artificial pancreas” innovation into an official, FDA-regulated product that will be broadly available via the iOS app store.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Insulin Delivery System Market including Animas Corporation (Johnson and Johnson), Becton, Dickinson and Company, Biocon Limited, Eli Lilly and Company, Insulet Corporation, Medtronic PLC, Novo Nordisk A/S, Sanofi, Tandem Diabetes Care, Inc., and Ypsomed Holding AG.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. The ongoing research amplifies the research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, d